|
Q3 2024
Filed on Nov 14, 2024
|
31,300
|
$0.0 - $26.42
$0 - $827K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
36,500
|
$13.7 - $17.0
$500K - $621K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
15,800
|
$17.13 - $23.17
$271K - $366K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
179,800
|
$9.2 - $12.82
$1.65M - $2.31M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,569
|
$180.0 - $225.24
$3.34M - $4.18M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
32,474
|
$125.79 - $216.71
$4.08M - $7.04M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,602
|
$4.63 - $7.46
$63K - $101K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
8,755
|
$59.4 - $70.22
$520K - $615K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
22,625
|
$0.53 - $0.77
$12K - $17.4K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
26,798
|
$0.7 - $1.06
$18.8K - $28.4K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,000
|
$6.45 - $12.04
$110K - $205K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
6,638
|
$332.02 - $382.76
$2.2M - $2.54M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
107,315
|
$70.09 - $78.74
$7.52M - $8.45M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,955
|
$1.96 - $4.08
$27.4K - $56.9K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
2,721
|
$113.85 - $140.68
$310K - $383K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
26,817
|
$30.32 - $41.21
$813K - $1.11M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
38,115
|
$10.38 - $11.87
$396K - $452K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,132
|
$1.35 - $1.9
$15K - $21.2K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
10,649
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
49,978
|
$0.5 - $1.71
$25K - $85.5K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
21,169
|
$30.96 - $39.45
$655K - $835K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
16,608
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
5,000,000
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,883
|
$9.92 - $13.51
$138K - $188K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
7,951
|
$27.28 - $39.1
$217K - $311K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
10,967
|
$24.66 - $34.26
$270K - $376K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
47,200
|
$13.62 - $15.59
$643K - $736K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
212,443
|
$14.36 - $16.0
$3.05M - $3.4M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
6,191
|
$87.69 - $127.47
$543K - $789K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
5,198
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
111,015
|
$1.77 - $2.72
$196K - $302K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
12,316
|
$0.45 - $0.71
$5.54K - $8.74K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
16,487
|
$55.61 - $74.71
$917K - $1.23M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
5,179
|
$56.02 - $66.68
$290K - $345K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
3,096
|
$58.38 - $80.96
$181K - $251K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
30,356
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,600
|
$27.17 - $32.96
$370K - $448K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
53,387
|
$40.84 - $45.74
$2.18M - $2.44M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
20,837
|
$76.27 - $95.27
$1.59M - $1.99M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
14,565
|
$0.7 - $0.82
$10.2K - $11.9K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
169,348
|
$2.08 - $3.5
$352K - $593K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
23,426
|
$20.48 - $33.15
$480K - $777K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,312
|
$0.48 - $13.79
$8.79K - $253K
|
|
Allarity Therapeutics Inc
|
Q3 2024
Filed on Nov 14, 2024
|
38,795
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,463
|
$0.54 - $0.92
$6.19K - $10.5K
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,400
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,733
|
N/A
|
|
Adverum Biotechnologies Inc
|
Q3 2024
Filed on Nov 14, 2024
|
24,203
|
N/A
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
281,000
|
$5.5 - $8.1
$1.55M - $2.28M
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
140,000
|
$1.81 - $8.13
$253K - $1.14M
|
|